JP2012515776A5 - - Google Patents

Download PDF

Info

Publication number
JP2012515776A5
JP2012515776A5 JP2011547997A JP2011547997A JP2012515776A5 JP 2012515776 A5 JP2012515776 A5 JP 2012515776A5 JP 2011547997 A JP2011547997 A JP 2011547997A JP 2011547997 A JP2011547997 A JP 2011547997A JP 2012515776 A5 JP2012515776 A5 JP 2012515776A5
Authority
JP
Japan
Prior art keywords
group
compound
salt according
heteroaryl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011547997A
Other languages
English (en)
Japanese (ja)
Other versions
JP5576402B2 (ja
JP2012515776A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/020373 external-priority patent/WO2010085377A2/en
Publication of JP2012515776A publication Critical patent/JP2012515776A/ja
Publication of JP2012515776A5 publication Critical patent/JP2012515776A5/ja
Application granted granted Critical
Publication of JP5576402B2 publication Critical patent/JP5576402B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011547997A 2009-01-23 2010-01-07 ヒドロキサム酸誘導体 Active JP5576402B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US14700209P 2009-01-23 2009-01-23
US61/147,002 2009-01-23
US15649609P 2009-02-28 2009-02-28
US61/156,496 2009-02-28
US25215609P 2009-10-15 2009-10-15
US61/252,156 2009-10-15
US25265209P 2009-10-17 2009-10-17
US61/252,652 2009-10-17
PCT/US2010/020373 WO2010085377A2 (en) 2009-01-23 2010-01-07 Hydroxamic acid derivatives

Publications (3)

Publication Number Publication Date
JP2012515776A JP2012515776A (ja) 2012-07-12
JP2012515776A5 true JP2012515776A5 (enExample) 2013-02-21
JP5576402B2 JP5576402B2 (ja) 2014-08-20

Family

ID=42356377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011547997A Active JP5576402B2 (ja) 2009-01-23 2010-01-07 ヒドロキサム酸誘導体

Country Status (17)

Country Link
US (3) US8609864B2 (enExample)
EP (1) EP2389375B1 (enExample)
JP (1) JP5576402B2 (enExample)
CN (1) CN102186842B (enExample)
CA (1) CA2750413C (enExample)
CY (1) CY1116602T1 (enExample)
DK (1) DK2389375T3 (enExample)
ES (1) ES2544803T3 (enExample)
HR (1) HRP20150778T1 (enExample)
HU (1) HUE025349T2 (enExample)
ME (1) ME02254B (enExample)
PL (1) PL2389375T3 (enExample)
PT (1) PT2389375E (enExample)
RS (1) RS54192B1 (enExample)
SI (1) SI2389375T1 (enExample)
SM (1) SMT201500196B (enExample)
WO (1) WO2010085377A2 (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2562175A1 (en) 2008-01-22 2013-02-27 Dow AgroSciences LLC 5-fluoro pyrimidine derivatives as fungicides
RS54192B1 (sr) * 2009-01-23 2015-12-31 Euro-Celtique S.A. Derivati hidroksamske kiseline
UA112284C2 (uk) 2009-08-07 2016-08-25 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні 5-фторпіримідинону
JP5784603B2 (ja) 2009-08-07 2015-09-24 ダウ アグロサイエンシィズ エルエルシー N1−スルホニル−5−フルオロピリミジノン誘導体
UA107671C2 (en) * 2009-08-07 2015-02-10 Dow Agrosciences Llc N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
UA106889C2 (uk) 2009-08-07 2014-10-27 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні n1-ацил-5-фторпіримідинону
CA2786250A1 (en) 2010-01-07 2011-07-14 Dow Agrosciences Llc Thiazolo[5,4-d] pyrimidines and their use as agrochemicals
CN101928234B (zh) * 2010-01-15 2012-12-12 北京欧凯纳斯科技有限公司 6/7-(杂)芳基-n-羟基己/庚酰胺化合物及其制备方法
WO2011113175A1 (zh) * 2010-03-15 2011-09-22 Gao Feng 阿糖胞苷前药衍生物及其在抗癌抗肿瘤中的用途
CN103313992B (zh) * 2011-01-12 2016-04-27 天堃医药科技(杭州)有限公司 具有hdac抑制作用的喜树碱衍生物
ES2646725T3 (es) 2011-08-17 2017-12-15 Adama Makhteshim Ltd. Derivados 1-sustituidos de 5-fluoro-3,6-dihidro-6-imino-2(1H)-pirimidinona como agentes fungicidas para uso en protección de plantas
CN102993102B (zh) * 2011-09-16 2016-08-24 杭州民生药业有限公司 [1-甲基-2-(7’-庚异羟肟酸基)-5-n,n-二(2’-氯乙基)]-1h-苯并咪唑的合成方法
MX346432B (es) * 2011-09-18 2017-03-21 Euro-Celtique S A * Composiciones farmaceuticas.
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
TWI573792B (zh) 2012-02-01 2017-03-11 歐陸斯迪公司 新穎治療劑
CN102584737A (zh) * 2012-02-07 2012-07-18 盛世泰科生物医药技术(苏州)有限公司 抑制组蛋白去乙酰酶的物质的组成和使用
EP2725029A1 (en) * 2012-10-29 2014-04-30 Laboratoire Biodim New antibacterial compounds and biological applications thereof
EP2945635A4 (en) 2012-12-28 2016-05-25 Dow Agrosciences Llc 1- (SUBSTITUTED BENZOYL) -5-FLUORO-4-IMINO-3-METHYL-3,4-DIHYDROPYRIMIDIN-2 (1H) -ONE DERIVATIVES
KR20150103096A (ko) 2012-12-28 2015-09-09 다우 아그로사이언시즈 엘엘씨 N-(치환된)-5-플루오로-4-이미노-3-메틸-2-옥소-3,4-디히드로피리미딘-1(2h)-카르복실레이트 유도체
MX2015008444A (es) 2012-12-28 2015-09-23 Dow Agrosciences Llc Derivados de n-(sustituido)-5-flouro-4-imino-3-metil-2-oxo-3,4-dih idropirimidin-1 (2h)-carboximida.
CA2894553C (en) 2012-12-31 2021-03-02 Dow Agrosciences Llc 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides
CN103340845B (zh) * 2013-06-26 2015-03-18 浙江省食品药品检验研究院 药物组合物
JP6212831B2 (ja) * 2013-12-04 2017-10-18 杭州源昶医薬科技有限公司 ゲムシタビン誘導体、該誘導体を含む組成物及び該誘導体の製薬用途
SG11201605377VA (en) 2013-12-31 2016-08-30 Adama Makhteshim Ltd 5-fluoro-4-imino-3-(alkyl/substituted alkyl)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one and processes for their preparation
EA030056B1 (ru) 2013-12-31 2018-06-29 Адама Мактешим Лтд. Синергетические фунгицидные смеси и синергетические фунгицидные композиции для борьбы с грибами
CA2934902C (en) 2014-02-03 2018-08-14 Halliburton Energy Services, Inc. Geomechanical and geophysical computational model for oil and gas stimulation and production
GB201409471D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
GB201409485D0 (en) * 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
GB201409488D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
AU2015338042A1 (en) * 2014-10-28 2017-04-27 Shionogi & Co., Ltd. Heterocyclic derivative having AMPK activating effect
CN108026057B (zh) 2015-05-22 2021-08-06 株式会社钟根堂 用作选择性组蛋白脱乙酰酶抑制剂的杂环烷基衍生化合物及含其的药物组合物
JP2018529681A (ja) * 2015-09-10 2018-10-11 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company シクロホスファミド及びイホスファミドのイムノアッセイ用の免疫原及びアッセイ接合体として用いるシクロホスファミド類似体
US11266631B2 (en) 2016-10-11 2022-03-08 Purdue Pharmaceutical Products L.P. Hodgkin lymphoma therapy
CN106905191B (zh) * 2017-03-05 2019-03-29 北京化工大学 一种含有羟肟酸基团的氮芥类化合物及其制备方法和用途
CN106883217B (zh) * 2017-04-01 2020-05-22 清华大学深圳研究生院 一种核苷碱基异羟肟酸衍生化合物及其制备方法与应用
GB201709402D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating t-pll
GB201709406D0 (en) 2017-06-13 2017-07-26 Euro-Cletique S A Compounds for treating TNBC
GB201709403D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating sarcoma
GB201709405D0 (en) * 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating ovarian cancer
EP3659307A4 (en) * 2017-07-28 2021-09-22 Yale University ANTI-CANCER PRODUCTS AND METHOD FOR MANUFACTURING AND USING THEREOF
AU2018337035B2 (en) 2017-09-21 2023-10-12 Becton, Dickinson And Company Demarcation template for hazardous contaminant testing
AU2018337650B2 (en) 2017-09-21 2025-04-24 Becton, Dickinson And Company High dynamic range assays in hazardous contaminant testing
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
CA3075773A1 (en) 2017-09-21 2019-03-28 Becton, Dickinson And Company Hazardous contaminant collection kit and rapid testing
CN108299313B (zh) * 2018-01-16 2020-10-02 长沙霍滋生物科技有限公司 一种化合物及其在药学上的应用
SG11202100411TA (en) * 2018-08-03 2021-02-25 Cellix Bio Private Ltd Compositions and methods for the treatment of cancer
CN109516957A (zh) * 2018-08-03 2019-03-26 杭州梯诺医药科技有限公司 Nl-101多晶型及其制备方法
EP3845544B1 (en) * 2018-09-01 2023-11-15 Beijing Showby Pharmaceutical Co., Ltd. Phosphate of platinum compound and preparation method therefor
AU2019400983B2 (en) 2018-12-18 2025-07-03 Mundipharma International Corporation Limited Compounds for treating multiple myeloma
JP7479385B2 (ja) 2019-01-28 2024-05-08 ベクトン・ディキンソン・アンド・カンパニー 一体化されたスワブ及び検査デバイスを有する有害汚染物質採取デバイス
CN112209884B (zh) * 2019-07-12 2022-11-11 杭州梯诺医药科技有限公司 1-h苯并咪唑衍生物、制备方法及其应用
CN113307829B (zh) * 2021-05-08 2022-05-24 苏州科技大学 一种以异羟肟酸衍生物为配体的铂(ii)配合物及其制备方法和应用
WO2024231293A1 (en) 2023-05-05 2024-11-14 Euro-Celtique S.A. Combinations for treating cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
EP2083005A1 (en) 2000-09-29 2009-07-29 TopoTarget UK Limited Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
US8227636B2 (en) * 2004-04-05 2012-07-24 Merck Hdac Research, Llc Histone deacetylase inhibitor prodrugs
WO2007134169A2 (en) 2006-05-10 2007-11-22 Nuada, Llc Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
GB0621160D0 (en) * 2006-10-24 2006-12-06 Imp College Innovations Ltd Compounds and uses thereof
WO2009100045A1 (en) * 2008-02-04 2009-08-13 Translational Genomics Research Institute Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
RS54192B1 (sr) * 2009-01-23 2015-12-31 Euro-Celtique S.A. Derivati hidroksamske kiseline

Similar Documents

Publication Publication Date Title
JP2012515776A5 (enExample)
JP2010511721A5 (enExample)
JP2011522789A5 (enExample)
JP2016503799A5 (enExample)
JP2013512915A5 (enExample)
JP2012508252A5 (enExample)
JP2014515406A5 (enExample)
JP2015517574A5 (enExample)
JP2014507421A5 (enExample)
CA2750413A1 (en) Hydroxamic acid derivatives
RU2020131276A (ru) Терапевтические соединения и композиции
JP2013537203A5 (enExample)
JP2013543845A5 (enExample)
JP2011513410A5 (enExample)
JP2014526533A5 (enExample)
JP2009143956A5 (enExample)
JP2016505614A5 (enExample)
JP2013147496A5 (ja) 有機金属錯体
JP2013525458A5 (enExample)
JP2013102146A5 (ja) 化合物
JP2013525080A5 (enExample)
JP2014527974A5 (enExample)
JP2014500870A5 (enExample)
JP2010501534A5 (enExample)
JP2012092103A5 (enExample)